Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Hilda de Vries"'
Autor:
Ivo J Huijbers, Rahmen Bin Ali, Colin Pritchard, Miranda Cozijnsen, Min‐Chul Kwon, Natalie Proost, Ji‐Ying Song, Hilda de Vries, Jitendra Badhai, Kate Sutherland, Paul Krimpenfort, Ewa M Michalak, Jos Jonkers, Anton Berns
Publikováno v:
EMBO Molecular Medicine, Vol 6, Iss 2, Pp 212-225 (2014)
Abstract Human cancers modeled in Genetically Engineered Mouse Models (GEMMs) can provide important mechanistic insights into the molecular basis of tumor development and enable testing of new intervention strategies. The inherent complexity of these
Externí odkaz:
https://doaj.org/article/eb23552beda443f999513453e1461b4a
Autor:
Anton Berns, Lodewyk F. A. Wessels, Hilda de Vries, Miranda Cozijnsen, Jan van der Vliet, Marieke van de Ven, Natalie Proost, Nanne Aben, Ana Teresa Avelar, Remco Nagel
Supplementary figure 4. Cell viability data based to generate the synergy plots in Figures 2 and 3.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01456a994a6da6126e64204a68188bf0
https://doi.org/10.1158/1535-7163.22509532
https://doi.org/10.1158/1535-7163.22509532
Autor:
Anton Berns, Lodewyk F. A. Wessels, Hilda de Vries, Miranda Cozijnsen, Jan van der Vliet, Marieke van de Ven, Natalie Proost, Nanne Aben, Ana Teresa Avelar, Remco Nagel
Supplementary figure 1A. Sequencing tracks of a part of the Zwilch gene targeted by a first unique sgRNA, with the wildtype sequence (top) and sgRNA treated sequence (bottom) shown. B. Tide analysis showing editing efficiency of the first Zwilch targ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21ef73071c7d28e426d7d94709434aa2
https://doi.org/10.1158/1535-7163.22509544.v1
https://doi.org/10.1158/1535-7163.22509544.v1
Autor:
Anton Berns, Lodewyk F. A. Wessels, Hilda de Vries, Miranda Cozijnsen, Jan van der Vliet, Marieke van de Ven, Natalie Proost, Nanne Aben, Ana Teresa Avelar, Remco Nagel
Supplementary figure 1C. Sequencing tracks of a part of the Zwilch gene targered by a second unique sgRNA, with the wildtype sequence (top) and sgRNA treated sequence (bottom) shown. D. Tide analysis showing editing efficiency of the second Zwilch ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f6fd98104475e560d4a7cde7f896998
https://doi.org/10.1158/1535-7163.22509541
https://doi.org/10.1158/1535-7163.22509541
Autor:
Anton Berns, Lodewyk F. A. Wessels, Hilda de Vries, Miranda Cozijnsen, Jan van der Vliet, Marieke van de Ven, Natalie Proost, Nanne Aben, Ana Teresa Avelar, Remco Nagel
Small cell lung cancer (SCLC) is generally regarded as very difficult to treat, mostly due to the development of metastases early in the disease and a quick relapse with resistant disease. SCLC patients initially show a good response to treatment wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a04d176849f4d65548e63a2edd89e66
https://doi.org/10.1158/1535-7163.c.6539323
https://doi.org/10.1158/1535-7163.c.6539323
Autor:
Anton Berns, Lodewyk F. A. Wessels, Hilda de Vries, Miranda Cozijnsen, Jan van der Vliet, Marieke van de Ven, Natalie Proost, Nanne Aben, Ana Teresa Avelar, Remco Nagel
Supplementary figure 2. Graphs showing the correlation between all three replicates of the genome�wide CRISPR�Cas9 screen at the start of the experiment (t=0) and at the final time point (t=14).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cc3314d2e626bd6d2dc47afc7a85e4a
https://doi.org/10.1158/1535-7163.22509538
https://doi.org/10.1158/1535-7163.22509538
Autor:
Anton Berns, Lodewyk F. A. Wessels, Hilda de Vries, Miranda Cozijnsen, Jan van der Vliet, Marieke van de Ven, Natalie Proost, Nanne Aben, Ana Teresa Avelar, Remco Nagel
Supplementary figure 3A and B. Graph representing the mRNA levels of MYC and MYCL1 in a panel of 63 human SCLC cell lines. Cut-offs for the analysis of low and high expressing cells were set as indicated. C. Graphs showing the 2log(IC50) for a select
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::189d9b2f2cfd0f68a01b350c82fa0533
https://doi.org/10.1158/1535-7163.22509535
https://doi.org/10.1158/1535-7163.22509535
Autor:
Anton Berns, Natalie Proost, Nanne Aben, Marieke van de Ven, Jan van der Vliet, Hilda de Vries, Remco Nagel, Lodewyk F. A. Wessels, Ana Teresa Avelar, Miranda Cozijnsen
Publikováno v:
Molecular Cancer Therapeutics. 18:762-770
Small cell lung cancer (SCLC) is generally regarded as very difficult to treat, mostly due to the development of metastases early in the disease and a quick relapse with resistant disease. SCLC patients initially show a good response to treatment wit
Autor:
Ewa M. Michalak, Anton Berns, Jos Jonkers, Kate D. Sutherland, Hilda de Vries, Jitendra Badhai, Rahmen Bin Ali, Miranda Cozijnsen, Natalie Proost, Colin Pritchard, Ivo J. Huijbers, Minchul Kwon, Ji-Ying Song, Paul Krimpenfort
Publikováno v:
EMBO Molecular Medicine
Human cancers modeled in Genetically Engineered Mouse Models (GEMMs) can provide important mechanistic insights into the molecular basis of tumor development and enable testing of new intervention strategies. The inherent complexity of these models,
Autor:
Hilda de Vries, Roberta Frapolli, Elena Gatti, Camilla Recordati, Michela Frenquelli, Maurizio D'Incalci, Marco Bianchi, Massimo Venturini, Antonello E. Spinelli, Francesco De Marchis, Luca Crippa, Renzo Boldorini, Eltjona Rrapaj, Rosanna Mezzapelle, Eugenio Scanziani, Claudio Doglioni, Massimo P. Crippa, Chiara Ceriotti, Laura Perani, Silvia Valtorta, Lorenza Pecciarini, Alessandro Preti, Rosa Maria Moresco, Anton Berns
Publikováno v:
Scientific Reports
Scientific reports (Nature Publishing Group) 6 (2016): 22850. doi:10.1038/srep22850
info:cnr-pdr/source/autori:Mezzapelle R.; Rrapaj E.; Gatti E.; Ceriotti C.; De Marchis F.; Preti A.; Spinelli A.E.; Perani L.; Venturini M.; Valtorta S.; Moresco R.M.; Pecciarini L.; Doglioni C.; Frenquelli M.; Crippa L.; Recordati C.; Scanziani E.; De Vries H.; Berns A.; Frapolli R.; Boldorini R.; D'Incalci M.; Bianchi M.E.; Crippa M.P./titolo:Human malignant mesothelioma is recapitulated in immunocompetent BALB%2Fc mice injected with murine AB cells/doi:10.1038%2Fsrep22850/rivista:Scientific reports (Nature Publishing Group)/anno:2016/pagina_da:22850/pagina_a:/intervallo_pagine:22850/volume:6
Scientific reports (Nature Publishing Group) 6 (2016): 22850. doi:10.1038/srep22850
info:cnr-pdr/source/autori:Mezzapelle R.; Rrapaj E.; Gatti E.; Ceriotti C.; De Marchis F.; Preti A.; Spinelli A.E.; Perani L.; Venturini M.; Valtorta S.; Moresco R.M.; Pecciarini L.; Doglioni C.; Frenquelli M.; Crippa L.; Recordati C.; Scanziani E.; De Vries H.; Berns A.; Frapolli R.; Boldorini R.; D'Incalci M.; Bianchi M.E.; Crippa M.P./titolo:Human malignant mesothelioma is recapitulated in immunocompetent BALB%2Fc mice injected with murine AB cells/doi:10.1038%2Fsrep22850/rivista:Scientific reports (Nature Publishing Group)/anno:2016/pagina_da:22850/pagina_a:/intervallo_pagine:22850/volume:6
Malignant Mesothelioma is a highly aggressive cancer, which is difficult to diagnose and treat. Here we describe the molecular, cellular and morphological characterization of a syngeneic system consisting of murine AB1, AB12 and AB22 mesothelioma cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4f0d217fdbf74b4817a5f3f99d5224a
http://hdl.handle.net/10281/117009
http://hdl.handle.net/10281/117009